Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
European Journal of Heart Failure|February 18, 2021
Use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure RegistryPeter M Becher, Benedikt Schrage, Giulia Ferrannini, et al.
The American Journal of Medicine|March 28, 2017
Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary SyndromeNuccia Morici, Stefano Savonitto, Claudio Ponticelli, et al.
Resuscitation Plus|March 15, 2024
Implementation of an extracorporeal resuscitation (ECPR) program for out-of-hospital cardiac arrest in Stockholm, Sweden: Feasibility, safety, and outcomeLis Frykler Abazi, Andreas Liliequist, Felix Böhm, et al.
International Journal of Cardiology|May 4, 2020
Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial designGianluigi Savarese, Camilla Settergren, Benedikt Schrage, et al.
European Heart Journal. Acute Cardiovascular Care|December 14, 2021
Clinical Frailty Scale classes are independently associated with 6-month mortality for patients after acute myocardial infarctionNiklas Ekerstad, Dariush Javadzadeh, Karen P Alexander, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2018
Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary SyndromeBarbara E Stähli, Anna Nozza, Ilse C Schrieks, et al.
European Heart Journal|October 10, 2024
Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reductionNikolaus Marx, Lars Rydén, Massimo Federici, et al.
Diabetes Care|June 16, 2018
Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary SyndromeIlse C Schrieks, Anna Nozza, Barbara E Stähli, et al.
Journal of the American Heart Association|July 29, 2025
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI TrialRobert F Storey, John Deanfield, Stefan James, et al.
European Heart Journal|November 16, 2020
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metforminGiulia Ferrannini, Hertzel Gerstein, Helen Martina Colhoun, et al.
Pageof 7